Apotex Inc Unclassified
FDA Approved Drugs

Apotex Inc Unclassified

FDA Approved Drugs Database

FDA approved drug product records including application numbers, product numbers, drug names, active ingredients, dosage forms, strengths, approval dates and regulatory status.

Unclassified
  • Total Records 38
  • Latest Approval Date -
  • Data Source FDA
  • First Approval Date -
All
194
View
Unclassified
38
View
Discontinued
114
View
OTC
2
View
RX
40
View
Company Overview

Company

Apotex Inc Unclassified

Country

Canada

Website

Visit Website

Email

Social Profiles

Company Snapshot

Apotex Inc Unclassified

150 Signet Drive, Toronto, Ontario, M9L 1T9

Canada

www.apotex.com/global/error-pages?initialRequestUrl=https%3a%2f%2fwww.apotex.com%2fglobal%2fdefault.asp View on Map
FDA Approved Drug Records ( 38 records )
-
Unclassified Application: 203404

Drug Name

BIMATOPROST

Product Number

1

Dosage Form

-

Strength

0.01%

Approval Date

-

203404 / 1

Active Ingredient

BIMATOPROST

Application Number

203404

Product Number

1

Dosage Form

-

Strength

0.01%

Approval Date

-

Regulatory Status

Unclassified

-
Unclassified Application: 211442

Drug Name

DAPAGLIFLOZIN

Product Number

1

Dosage Form

-

Strength

5MG

Approval Date

-

211442 / 1

Active Ingredient

DAPAGLIFLOZIN

Application Number

211442

Product Number

1

Dosage Form

-

Strength

5MG

Approval Date

-

Regulatory Status

Unclassified

-
Unclassified Application: 211442

Drug Name

DAPAGLIFLOZIN

Product Number

2

Dosage Form

-

Strength

10MG

Approval Date

-

211442 / 2

Active Ingredient

DAPAGLIFLOZIN

Application Number

211442

Product Number

2

Dosage Form

-

Strength

10MG

Approval Date

-

Regulatory Status

Unclassified

-
Unclassified Application: 201536

Drug Name

ELETRIPTAN HYDROBROMIDE

Product Number

1

Dosage Form

-

Strength

20MG

Approval Date

-

201536 / 1

Active Ingredient

ELETRIPTAN HYDROBROMIDE

Application Number

201536

Product Number

1

Dosage Form

-

Strength

20MG

Approval Date

-

Regulatory Status

Unclassified

-
Unclassified Application: 201536

Drug Name

ELETRIPTAN HYDROBROMIDE

Product Number

2

Dosage Form

-

Strength

40MG

Approval Date

-

201536 / 2

Active Ingredient

ELETRIPTAN HYDROBROMIDE

Application Number

201536

Product Number

2

Dosage Form

-

Strength

40MG

Approval Date

-

Regulatory Status

Unclassified

-
Unclassified Application: 218575

Drug Name

ELVITEGRAVIR, COBICISTAT, EMTRICITABINE AND TENOFOVIR ALAFENAMIDE

Product Number

2

Dosage Form

-

Strength

150MG

Approval Date

-

218575 / 2

Active Ingredient

ELVITEGRAVIR, COBICISTAT, EMTRICITABINE AND TENOFOVIR ALAFENAMIDE

Application Number

218575

Product Number

2

Dosage Form

-

Strength

150MG

Approval Date

-

Regulatory Status

Unclassified

-
Unclassified Application: 218575

Drug Name

ELVITEGRAVIR, COBICISTAT, EMTRICITABINE AND TENOFOVIR ALAFENAMIDE

Product Number

3

Dosage Form

-

Strength

200MG

Approval Date

-

218575 / 3

Active Ingredient

ELVITEGRAVIR, COBICISTAT, EMTRICITABINE AND TENOFOVIR ALAFENAMIDE

Application Number

218575

Product Number

3

Dosage Form

-

Strength

200MG

Approval Date

-

Regulatory Status

Unclassified

-
Unclassified Application: 218575

Drug Name

ELVITEGRAVIR, COBICISTAT, EMTRICITABINE AND TENOFOVIR ALAFENAMIDE

Product Number

4

Dosage Form

-

Strength

6MG

Approval Date

-

218575 / 4

Active Ingredient

ELVITEGRAVIR, COBICISTAT, EMTRICITABINE AND TENOFOVIR ALAFENAMIDE

Application Number

218575

Product Number

4

Dosage Form

-

Strength

6MG

Approval Date

-

Regulatory Status

Unclassified

-
Unclassified Application: 218575

Drug Name

ELVITEGRAVIR, COBICISTAT, EMTRICITABINE AND TENOFOVIR ALAFENAMIDE

Product Number

5

Dosage Form

-

Strength

90MG

Approval Date

-

218575 / 5

Active Ingredient

ELVITEGRAVIR, COBICISTAT, EMTRICITABINE AND TENOFOVIR ALAFENAMIDE

Application Number

218575

Product Number

5

Dosage Form

-

Strength

90MG

Approval Date

-

Regulatory Status

Unclassified

-
Unclassified Application: 218575

Drug Name

ELVITEGRAVIR, COBICISTAT, EMTRICITABINE AND TENOFOVIR ALAFENAMIDE

Product Number

6

Dosage Form

-

Strength

120MG

Approval Date

-

218575 / 6

Active Ingredient

ELVITEGRAVIR, COBICISTAT, EMTRICITABINE AND TENOFOVIR ALAFENAMIDE

Application Number

218575

Product Number

6

Dosage Form

-

Strength

120MG

Approval Date

-

Regulatory Status

Unclassified

-
Unclassified Application: 216108

Drug Name

FENFLURAMINE

Product Number

1

Dosage Form

-

Strength

2.2MG/ML

Approval Date

-

216108 / 1

Active Ingredient

FENFLURAMINE

Application Number

216108

Product Number

1

Dosage Form

-

Strength

2.2MG/ML

Approval Date

-

Regulatory Status

Unclassified

-
Unclassified Application: 201505

Drug Name

IRBESARTAN HYDROCHLOROTHIAZIDE

Product Number

3

Dosage Form

-

Strength

25MG;300MG

Approval Date

-

201505 / 3

Active Ingredient

HYDROCHLOROTHIAZIDE; IRBESARTAN

Application Number

201505

Product Number

3

Dosage Form

-

Strength

25MG;300MG

Approval Date

-

Regulatory Status

Unclassified

-
Unclassified Application: 211528

Drug Name

LEVOCETIRIZINE DIHYDROCHLORIDE

Product Number

1

Dosage Form

-

Strength

2.5MG/5ML

Approval Date

-

211528 / 1

Active Ingredient

LEVOCETIRIZINE DIHYDROCHLORIDE

Application Number

211528

Product Number

1

Dosage Form

-

Strength

2.5MG/5ML

Approval Date

-

Regulatory Status

Unclassified

-
Unclassified Application: 219450

Drug Name

OZANIMOD

Product Number

2

Dosage Form

-

Strength

0.46MG

Approval Date

-

219450 / 2

Active Ingredient

OZANIMOD

Application Number

219450

Product Number

2

Dosage Form

-

Strength

0.46MG

Approval Date

-

Regulatory Status

Unclassified

-
Unclassified Application: 219450

Drug Name

OZANIMOD

Product Number

3

Dosage Form

-

Strength

0.23MG

Approval Date

-

219450 / 3

Active Ingredient

OZANIMOD

Application Number

219450

Product Number

3

Dosage Form

-

Strength

0.23MG

Approval Date

-

Regulatory Status

Unclassified

-
Unclassified Application: 202998

Drug Name

PREGABALIN

Product Number

1

Dosage Form

-

Strength

20MG/ML

Approval Date

-

202998 / 1

Active Ingredient

PREGABALIN

Application Number

202998

Product Number

1

Dosage Form

-

Strength

20MG/ML

Approval Date

-

Regulatory Status

Unclassified

-
Unclassified Application: 203022

Drug Name

PREGABALIN

Product Number

1

Dosage Form

-

Strength

25MG

Approval Date

-

203022 / 1

Active Ingredient

PREGABALIN

Application Number

203022

Product Number

1

Dosage Form

-

Strength

25MG

Approval Date

-

Regulatory Status

Unclassified

-
Unclassified Application: 203022

Drug Name

PREGABALIN

Product Number

2

Dosage Form

-

Strength

50MG

Approval Date

-

203022 / 2

Active Ingredient

PREGABALIN

Application Number

203022

Product Number

2

Dosage Form

-

Strength

50MG

Approval Date

-

Regulatory Status

Unclassified

-
Unclassified Application: 203022

Drug Name

PREGABALIN

Product Number

3

Dosage Form

-

Strength

75MG

Approval Date

-

203022 / 3

Active Ingredient

PREGABALIN

Application Number

203022

Product Number

3

Dosage Form

-

Strength

75MG

Approval Date

-

Regulatory Status

Unclassified

-
Unclassified Application: 203022

Drug Name

PREGABALIN

Product Number

4

Dosage Form

-

Strength

100MG

Approval Date

-

203022 / 4

Active Ingredient

PREGABALIN

Application Number

203022

Product Number

4

Dosage Form

-

Strength

100MG

Approval Date

-

Regulatory Status

Unclassified

-
Unclassified Application: 203022

Drug Name

PREGABALIN

Product Number

5

Dosage Form

-

Strength

150MG

Approval Date

-

203022 / 5

Active Ingredient

PREGABALIN

Application Number

203022

Product Number

5

Dosage Form

-

Strength

150MG

Approval Date

-

Regulatory Status

Unclassified

-
Unclassified Application: 203022

Drug Name

PREGABALIN

Product Number

6

Dosage Form

-

Strength

200MG

Approval Date

-

203022 / 6

Active Ingredient

PREGABALIN

Application Number

203022

Product Number

6

Dosage Form

-

Strength

200MG

Approval Date

-

Regulatory Status

Unclassified

-
Unclassified Application: 203022

Drug Name

PREGABALIN

Product Number

7

Dosage Form

-

Strength

225MG

Approval Date

-

203022 / 7

Active Ingredient

PREGABALIN

Application Number

203022

Product Number

7

Dosage Form

-

Strength

225MG

Approval Date

-

Regulatory Status

Unclassified

-
Unclassified Application: 203022

Drug Name

PREGABALIN

Product Number

8

Dosage Form

-

Strength

300MG

Approval Date

-

203022 / 8

Active Ingredient

PREGABALIN

Application Number

203022

Product Number

8

Dosage Form

-

Strength

300MG

Approval Date

-

Regulatory Status

Unclassified

-
Unclassified Application: 208869

Drug Name

RUXOLITINIB

Product Number

2

Dosage Form

-

Strength

10MG

Approval Date

-

208869 / 2

Active Ingredient

RUXOLITINIB

Application Number

208869

Product Number

2

Dosage Form

-

Strength

10MG

Approval Date

-

Regulatory Status

Unclassified

-
Unclassified Application: 208869

Drug Name

RUXOLITINIB

Product Number

3

Dosage Form

-

Strength

15MG

Approval Date

-

208869 / 3

Active Ingredient

RUXOLITINIB

Application Number

208869

Product Number

3

Dosage Form

-

Strength

15MG

Approval Date

-

Regulatory Status

Unclassified

-
Unclassified Application: 208869

Drug Name

RUXOLITINIB

Product Number

4

Dosage Form

-

Strength

20MG

Approval Date

-

208869 / 4

Active Ingredient

RUXOLITINIB

Application Number

208869

Product Number

4

Dosage Form

-

Strength

20MG

Approval Date

-

Regulatory Status

Unclassified

-
Unclassified Application: 208869

Drug Name

RUXOLITINIB

Product Number

5

Dosage Form

-

Strength

25MG

Approval Date

-

208869 / 5

Active Ingredient

RUXOLITINIB

Application Number

208869

Product Number

5

Dosage Form

-

Strength

25MG

Approval Date

-

Regulatory Status

Unclassified

-
Unclassified Application: 220314

Drug Name

SEMAGLUTIDE

Product Number

1

Dosage Form

-

Strength

2MG/3ML

Approval Date

-

220314 / 1

Active Ingredient

SEMAGLUTIDE

Application Number

220314

Product Number

1

Dosage Form

-

Strength

2MG/3ML

Approval Date

-

Regulatory Status

Unclassified

-
Unclassified Application: 220314

Drug Name

SEMAGLUTIDE

Product Number

2

Dosage Form

-

Strength

4MG/3ML

Approval Date

-

220314 / 2

Active Ingredient

SEMAGLUTIDE

Application Number

220314

Product Number

2

Dosage Form

-

Strength

4MG/3ML

Approval Date

-

Regulatory Status

Unclassified

-
Unclassified Application: 220314

Drug Name

SEMAGLUTIDE

Product Number

3

Dosage Form

-

Strength

8MG/3ML

Approval Date

-

220314 / 3

Active Ingredient

SEMAGLUTIDE

Application Number

220314

Product Number

3

Dosage Form

-

Strength

8MG/3ML

Approval Date

-

Regulatory Status

Unclassified

-
Unclassified Application: 214494

Drug Name

SITAGLIPTIN AND METFORMIN HYDROCHLORIDE

Product Number

2

Dosage Form

-

Strength

100MG

Approval Date

-

214494 / 2

Active Ingredient

METFORMIN HYDROCHLORIDE, SITAGLIPTIN

Application Number

214494

Product Number

2

Dosage Form

-

Strength

100MG

Approval Date

-

Regulatory Status

Unclassified

-
Unclassified Application: 214494

Drug Name

SITAGLIPTIN AND METFORMIN HYDROCHLORIDE

Product Number

3

Dosage Form

-

Strength

50MG

Approval Date

-

214494 / 3

Active Ingredient

METFORMIN HYDROCHLORIDE, SITAGLIPTIN

Application Number

214494

Product Number

3

Dosage Form

-

Strength

50MG

Approval Date

-

Regulatory Status

Unclassified

-
Unclassified Application: 214494

Drug Name

SITAGLIPTIN AND METFORMIN HYDROCHLORIDE

Product Number

4

Dosage Form

-

Strength

500MG

Approval Date

-

214494 / 4

Active Ingredient

METFORMIN HYDROCHLORIDE, SITAGLIPTIN

Application Number

214494

Product Number

4

Dosage Form

-

Strength

500MG

Approval Date

-

Regulatory Status

Unclassified

-
Unclassified Application: 211130

Drug Name

VORTIOXETINE HYDROBROMIDE

Product Number

2

Dosage Form

-

Strength

10MG

Approval Date

-

211130 / 2

Active Ingredient

VORTIOXETINE HYDROBROMIDE

Application Number

211130

Product Number

2

Dosage Form

-

Strength

10MG

Approval Date

-

Regulatory Status

Unclassified

-
Unclassified Application: 211130

Drug Name

VORTIOXETINE HYDROBROMIDE

Product Number

3

Dosage Form

-

Strength

15MG

Approval Date

-

211130 / 3

Active Ingredient

VORTIOXETINE HYDROBROMIDE

Application Number

211130

Product Number

3

Dosage Form

-

Strength

15MG

Approval Date

-

Regulatory Status

Unclassified

-
Unclassified Application: 211130

Drug Name

VORTIOXETINE HYDROBROMIDE

Product Number

4

Dosage Form

-

Strength

5MG

Approval Date

-

211130 / 4

Active Ingredient

VORTIOXETINE HYDROBROMIDE

Application Number

211130

Product Number

4

Dosage Form

-

Strength

5MG

Approval Date

-

Regulatory Status

Unclassified

-
Unclassified Application: 78533

Drug Name

ZOLEDRONIC ACID

Product Number

1

Dosage Form

-

Strength

EQ 4MG BASE/5ML

Approval Date

-

78533 / 1

Active Ingredient

ZOLEDRONIC ACID

Application Number

78533

Product Number

1

Dosage Form

-

Strength

EQ 4MG BASE/5ML

Approval Date

-

Regulatory Status

Unclassified

Related Databases
  • FDA Inspections
    9 View
  • EDQM CEP
    0 View
  • KDMF
    0 View
  • Japan DMF
    0 View
  • Eudra GMP
    2 View
  • NDC Database
    0 View
  • FDA Approved Drugs Database
    194 View
  • Drug Prices in Switzerland
    0 View
Drug Status Breakdown
38 total
  • Unclassified
Official Source

FDA approved drug data is based on publicly available U.S. Food and Drug Administration Orange Book information.

Visit FDA Orange Book
FDA Approved Drug Record Details Preview

Explore important FDA approved drug information available in the records above.

Drug Name

BIMATOPROST

Application Number

203404

Product Number

1

Active Ingredient

BIMATOPROST

Dosage Form

-

Strength

0.01%

FDA Approved Drug Data

Approved drug product information

Regular Updates

Data maintained from official sources

Structured Database

Searchable pharmaceutical data

Reliable Data

Organized FDA drug records

Create a New Buying Request

Fields marked with * are mandatory.

Please enter quantity.
Please select a unit.
Please select quality standard.
Please select request type.
Please provide product specifications.
Please enter additional details.
Please select shipping preference.
Notice: By submitting this buying request, the provided product details and requirements may be published publicly on our marketplace.
Login to Submit